EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts

Daniela Benati iD, Eleonora Cattin iD, Federico Corradi iD, Tommaso Ferrari iD, Eleonora Pedrazzoli, Clarissa Patrizi, Matteo Marchionni iD, Roberto Bertorelli iD, Veronica De Sanctis iD, Luciano Merlini, Alessandra Ferlini iD, Patrizia Sabatelli und 2 weitere

Biomolecules · 2024

DOI: 10.3390/biom14111412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Daniela Benati und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Collagen Type VI, Fibroblasts, Gene Editing, Extracellular Matrix. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cure CMD, Million Dollar Bike Ride Award 2018—Orphan Disease Center, Pennsylvania University (UPENN) (Principal investigator, AR), European Union—Next Generation EU, Mission 4, Component 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Collagen VI is an essential component of the extracellular matrix (ECM) composed by α1, α2 and α3 chains and encoded by COL6A1, COL6A2 and COL6A3 genes. Dominant negative pathogenic variants in COL6A genes result in defects in collagen VI protein and are implicated in the pathogenesis of muscular diseases, including Ullrich congenital muscular dystrophy (UCMD). Here, we designed a CRISPR genome editing strategy to tackle a dominant heterozygous deletion c.824_838del in exon 9 of the COL6A1 gene, causing a lack of secreted collagen VI in a patient’s dermal fibroblasts. The evaluation of efficiency and specificity of gene editing in treating patient’s fibroblasts revealed the 32% efficiency of editing the mutated allele but negligible editing of the wild-type allele. CRISPR-treated UCMD skin fibroblasts rescued the secretion of collagen VI in the ECM, which restored the ultrastructure of the collagen VI microfibril network. By using normal melanocytes as surrogates of muscle cells, we found that collagen VI secreted by the corrected patient’s skin fibroblasts recovered the anchorage to the cell surface, pointing to a functional improvement of the protein properties. These results support the application of the CRISPR editing approach to knock out COL6A1 mutated alleles and rescue the UCMD phenotype in patient-derived fibroblasts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type VIFibroblastsGene EditingExtracellular MatrixMuscular DystrophiesCRISPR-Cas SystemsHumansSclerosisMutation

Stichwörter der Autor:innen

CRISPR/Cas9allele-specific gene editingcollagen VIcollagen VI-related disorderspatient-derived fibroblasts

Substanzen

Collagen Type VICol6a1 protein, human

Autor:innen und Institutionen

  • Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Next Generation Sequencing Core Facility Department of Cellular, Computational and Integrative Biomedicine-CIBIO LaBSSAH, University of Trento, 38122 Trento, Italy.
  • Department of Biomedical and Neuromotor Science, DIBINEM, University of Bologna, 40136 Bologna, Italy.
  • Section of Medical Genetics, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • Unit of Medical Genetics, Department of Mother and Child, University Hospital S. Anna Ferrara, 44121 Ferrara, Italy.
  • CNR-Institute of Molecular Genetics, 40136 Bologna, Italy.

ORCID-Profile: Daniela Benati, Eleonora Cattin, Federico Corradi, Tommaso Ferrari, Matteo Marchionni, Roberto Bertorelli, Veronica De Sanctis, Alessandra Ferlini, Francesca Gualandi, Alessandra Recchia

Förderung

  • Cure CMD
  • Million Dollar Bike Ride Award 2018—Orphan Disease Center, Pennsylvania University (UPENN) (Principal investigator, AR)
  • European Union—Next Generation EU, Mission 4, Component 2
  • PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR) Missione 4 “Istruzione e Ricerca”—Componente C2 Investimento 1.1
  • Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale (PRIN)
  • Umberto Veronesi Foundation (Italy)
  • European Reference Network for Neuromuscular diseases (ERN Euro-NMD, AF and GF representatives)

Zitieren

APA

Benati, D., Cattin, E., Corradi, F., Ferrari, T., Pedrazzoli, E., Patrizi, C., Marchionni, M., Bertorelli, R., De Sanctis, V., Merlini, L., Ferlini, A., Sabatelli, P., Gualandi, F., & Recchia, A. (2024). Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts. Biomolecules. https://doi.org/10.3390/biom14111412

Vancouver

Benati D, Cattin E, Corradi F, Ferrari T, Pedrazzoli E, Patrizi C, et al. Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts. Biomolecules. 2024. doi:10.3390/biom14111412

BibTeX
@article{Benati2024,
  author = {Benati, Daniela and Cattin, Eleonora and Corradi, Federico and Ferrari, Tommaso and Pedrazzoli, Eleonora and Patrizi, Clarissa and Marchionni, Matteo and Bertorelli, Roberto and De Sanctis, Veronica and Merlini, Luciano and Ferlini, Alessandra and Sabatelli, Patrizia and Gualandi, Francesca and Recchia, Alessandra},
  title = {Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14111412}
}
Kostenlos starten →